Impax Laboratories Inc (NASDAQ:IPXL)

45.46
Delayed Data
As of May 21
 +0.35 / +0.78%
Today’s Change
22.12
Today|||52-Week Range
52.10
+43.50%
Year-to-Date

Today’s Trading

Previous close45.11
Today’s open44.97
Day’s range-- - --
Volume796,844
Average volume (3 months)720,773
Market cap$3.2B
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+2.24%
Earnings growth (next 5 years)+25.66%
Revenue growth (last year)+16.53%
P/E ratio71.7
Price/Sales3.62
Price/Book3.62

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-1.14-1.24%
WXWuXi PharmaTech (Cay...+0.34+0.79%
RAREUltragenyx Pharmaceu...+0.37+0.44%
ANACAnacor Pharmaceutica...-0.59-0.92%
Data as of 05/21/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)$0.17
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers